Literature DB >> 15556761

Optimization of unique, uncharged thioesters as inhibitors of HIV replication.

Pratibha Srivastava1, Marco Schito, Rasem J Fattah, Toshiaki Hara, Tracy Hartman, Robert W Buckheit, Jim A Turpin, John K Inman, Ettore Appella.   

Abstract

A combinatorial chemistry approach was employed to prepare a restricted library of N-substituted S-acyl-2-mercaptobenzamide thioesters. It was shown that many members of this chemotype display anti-HIV activity via their ability to interact with HIV-1, HIV-2, SIV-infected cells, cell-free virus, and chronically and latently infected cells in a manner consistent with targeting of the highly conserved HIV-1 NCp7 zinc fingers. Compounds were initially screened using two different in vitro antiviral assays and evaluated for stability in neutral buffer containing 10% pooled human serum using a spectrophotometric assay. These data revealed that there was no significant correlation between thioester stability and antiviral activity, however, a slight inverse correlation between serum stability and virucidal activity was noted. Based on the virucidal capability and the ability to select lead compounds to inhibit virus expression from latently infected TNFalpha-induced U1 cells, we next determined if these compounds could prevent HIV cell-to-cell transmission. Several thioesters demonstrated potent inhibition of HIV cell-to-cell transmission with EC50 values in the 80-100 nM range. Thus, we have optimized a series of restricted thioesters and provided evidence that serum stability is not required for antiviral activity. Moreover, selected compounds show potential for development as topical microbicides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15556761     DOI: 10.1016/j.bmc.2004.09.032

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  19 in total

1.  A one-pot preparation of N-2-mercaptobenzoyl-amino amides.

Authors:  Robert J Bahde; Daniel H Appella; William C Trenkle
Journal:  Tetrahedron Lett       Date:  2011-08-10       Impact factor: 2.415

2.  Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide.

Authors:  Cecilia Cheng-Mayer; Yaoxing Huang; Agegnehu Gettie; Lily Tsai; Wuze Ren; Madina Shakirzyanova; Silvana T Sina; Nataliya Trunova; James Blanchard; Lisa M Miller Jenkins; Yungtai Lo; Marco L Schito; Ettore Appella
Journal:  AIDS       Date:  2011-09-24       Impact factor: 4.177

Review 3.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

Review 4.  HIV type 1 Gag as a target for antiviral therapy.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-21       Impact factor: 2.205

Review 5.  Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.

Authors:  Divita Garg; Bruce E Torbett
Journal:  Virus Res       Date:  2014-07-12       Impact factor: 3.303

6.  An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission.

Authors:  Shweta R Ugaonkar; Justin T Clark; Lexie B English; Todd J Johnson; Karen W Buckheit; Robert J Bahde; Daniel H Appella; Robert W Buckheit; Patrick F Kiser
Journal:  J Pharm Sci       Date:  2015-07-06       Impact factor: 3.534

7.  Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings.

Authors:  Todd J Johnson; Priya Srinivasan; Theodore H Albright; Karen Watson-Buckheit; Lorna Rabe; Amy Martin; Chou-Pong Pau; R Michael Hendry; Ron Otten; Janet McNicholl; Robert Buckheit; James Smith; Patrick F Kiser
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

8.  Anisotropic, Polarizable Molecular Mechanics Studies of Inter- and Intramolecular Interactions and Ligand-Macromolecule Complexes. A Bottom-Up Strategy.

Authors:  Nohad Gresh; G Andrés Cisneros; Thomas A Darden; Jean-Philip Piquemal
Journal:  J Chem Theory Comput       Date:  2007-11       Impact factor: 6.006

9.  Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infection.

Authors:  Gregory S Wallace; Cecilia Cheng-Mayer; Marco L Schito; Patricia Fletcher; Lisa M Miller Jenkins; Ryo Hayashi; A Robert Neurath; Ettore Appella; Robin J Shattock
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

10.  Targeting a Dark Excited State of HIV-1 Nucleocapsid by Antiretroviral Thioesters Revealed by NMR Spectroscopy.

Authors:  Lalit Deshmukh; Vitali Tugarinov; Daniel H Appella; G Marius Clore
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-02       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.